WO1993025176A1 - Freezing bags - Google Patents

Freezing bags Download PDF

Info

Publication number
WO1993025176A1
WO1993025176A1 PCT/GB1993/000975 GB9300975W WO9325176A1 WO 1993025176 A1 WO1993025176 A1 WO 1993025176A1 GB 9300975 W GB9300975 W GB 9300975W WO 9325176 A1 WO9325176 A1 WO 9325176A1
Authority
WO
WIPO (PCT)
Prior art keywords
bag
freezing
outlet port
cryoprotectant
freezing bag
Prior art date
Application number
PCT/GB1993/000975
Other languages
French (fr)
Inventor
Michael John Glynn Thomas
Stuart Graham Nash
Original Assignee
The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland filed Critical The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland
Priority to GB9400647A priority Critical patent/GB2272883B/en
Publication of WO1993025176A1 publication Critical patent/WO1993025176A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02Blood transfusion apparatus
    • A61M1/0209Multiple bag systems for separating or storing blood components

Definitions

  • the present invention relates to bags for use in the preservation of blood cells.
  • Blood used for transfusion is normally stored in refrigerators, where its safe life is only five weeks. Potentially longer storage life might be obtained by freezing, but unfortunately freezing blood as obtained from a donor results in destruction of the red blood cells making the blood totally unsuitable for transfusions. Red blood cells can be stored after separation, by centrifuging, from the associated plasma, mixing with a cryoprotectant, and then freezing.
  • the usual cryoprotectant is glycerol. As glycerol itself is poisonous frozen cells must have all the glycerol removed therefrom before being used for transfusion, and the necessary washing process is a skilled and time-consuming task which usually results in a significant loss of usable cells.
  • HES hydroxyethvl starch
  • the bags used in the method of PCT/GB90/0140 must be capable of fulfilling stringent criteria. Freezing is carried out in liquid nitrogen, and the manner in which the unavoidable changes in volume of the mixture of red blood cells and cryoprotectant during freezing are accommodated must be carefully controlled. It is also important that the concentration of HES is within stringent limits, and that the donation process is carried out in a sterile manner. It has been suggested that the HES be stored in the freezing bag itself. However it has been found that materials, suitable for the bag tend to be slightly porous, so that the moisture content of HES within a bag varies during storage, the nature of the variation being dependant on the atmospheric humidity of the store.
  • bags which must, of course, be stored at sub-zero temperatures, should be of a convenient shape for storage, and that it should be possible to directly tap into a bag for transfusion purposes. Bags which fulfil this criterion are described in Patent Applications PCT/GB88/00947 and PCT/US91/00192.
  • the manner of extraction from these involves penetration by a needle of the bottom fold of a pouch which extends inwardly of the bag. This procedure requires equipment which is not standard, and also requires new skills to be learnt by personnel giving transfusions.
  • a freezing bag has an inlet port connected to an inlet tube to characterised in that the inlet tube is connected a cryoprotectant storage bag having an impervious cover, and an outlet port, the inlet tube and the outlet port each having a breakable seal.
  • the impervious cover might be the actual material of the bag, or might be a separate cover surrounding the bag.
  • the bag will normally be of generally rectangular, usually square, shape.
  • the inlet port and outlet port will usually be on the same edge of the bag, with the outlet port preferably towards the centre of the edge, advantageously being slightly offset from the centre.
  • Figure 1 is a view of a bag according to the invention.
  • Figure 2 is a view, in section along line II-II of Figure 1, of a cryoprotectant storage bag.
  • a freezing bag 10 ( Figure 1) suitable for use with the method of PCT/GB90/140 has, situated at one end of an edge 20, an inlet port 11 connected to a tube 12 having a breakable seal 13-
  • a branch 14 from the tube 12 leads to a cryoprotectant storage bag 15 which is surrounded by a cover 16 (see Figure 2) made of impervious material.
  • the cover 16 extends for a sufficient length of the branch 14 to insure that it will overlie any position to which cryoprotectant will penetrate.
  • the outlet port 17 and seal 18 might conveniently be of the type used on conventional (non- frozen) storage bags.
  • the cover 16 is removed from the cryoprotectant storage bag 15 and the breakable seal 13 removed from the tube 12, which is connected to a red blood cell supply (not shown) in known manner.
  • Blood from a donor is centrifuged and the red cells therefrom passed through the tube 12 to the bag 10, cryoprotectant from the cryoprotectant storage bag 15 being passed through the branch 14 and tube 12 at the same time.
  • the bag is then sealed, for example by thermally sealing along a line 19, in known fashion, and then removing the inlet port 11 and associated items.
  • the bag 10 is then shaken to mix the red blood cells and cryoprotectant, frozen and stored according to the method of PCT/GB90/140.
  • cryoprotectant storage bag 15 might be formed of impermeable material, there then being no need for a separate cover 16. However this arrangement makes it harder to protect cryoprotectant entering the branch 14.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)

Abstract

A freezing bag (10) has an inlet port (11) connected to an inlet tube (12) having a breakable seal (13) and to which is connected a cryoprotectant storage bag (15) which is surrounded by an impervious cover (16), and an outlet port (17) having a breakable seal (18).

Description

FREEZING BAGS
The present invention relates to bags for use in the preservation of blood cells.
Blood used for transfusion is normally stored in refrigerators, where its safe life is only five weeks. Potentially longer storage life might be obtained by freezing, but unfortunately freezing blood as obtained from a donor results in destruction of the red blood cells making the blood totally unsuitable for transfusions. Red blood cells can be stored after separation, by centrifuging, from the associated plasma, mixing with a cryoprotectant, and then freezing. The usual cryoprotectant is glycerol. As glycerol itself is poisonous frozen cells must have all the glycerol removed therefrom before being used for transfusion, and the necessary washing process is a skilled and time-consuming task which usually results in a significant loss of usable cells. Another cryoprotectant is hydroxyethvl starch (HES) , which is non-toxic, and much work has been carried out on methods of preserving red blood cells using this substance. Early efforts were unsuccessful, as it was found that the level of haemolysis (breakdown of red blood cells) in units of blood (a unit of blood being the volume of a standard donation, about 450ml) recovered after freezing was above the safe limit. It is usually considered that to be safe for transfusion the level of haemolysis should be no greater the- 1% . A method of preserving and recovering red blood corpuscule Dy freezing, using HES as a cryoprotectant, wherein the level of haemolysis after recovery is within acceptable limits, has now been developed and is described in Patent Application PCT/GB90/0140.
The bags used in the method of PCT/GB90/0140 must be capable of fulfilling stringent criteria. Freezing is carried out in liquid nitrogen, and the manner in which the unavoidable changes in volume of the mixture of red blood cells and cryoprotectant during freezing are accommodated must be carefully controlled. It is also important that the concentration of HES is within stringent limits, and that the donation process is carried out in a sterile manner. It has been suggested that the HES be stored in the freezing bag itself. However it has been found that materials, suitable for the bag tend to be slightly porous, so that the moisture content of HES within a bag varies during storage, the nature of the variation being dependant on the atmospheric humidity of the store.
It is also important that the bags, which must, of course, be stored at sub-zero temperatures, should be of a convenient shape for storage, and that it should be possible to directly tap into a bag for transfusion purposes. Bags which fulfil this criterion are described in Patent Applications PCT/GB88/00947 and PCT/US91/00192. The manner of extraction from these involves penetration by a needle of the bottom fold of a pouch which extends inwardly of the bag. This procedure requires equipment which is not standard, and also requires new skills to be learnt by personnel giving transfusions. According to the present invention a freezing bag has an inlet port connected to an inlet tube to characterised in that the inlet tube is connected a cryoprotectant storage bag having an impervious cover, and an outlet port, the inlet tube and the outlet port each having a breakable seal. The impervious cover might be the actual material of the bag, or might be a separate cover surrounding the bag.
The bag will normally be of generally rectangular, usually square, shape. The inlet port and outlet port will usually be on the same edge of the bag, with the outlet port preferably towards the centre of the edge, advantageously being slightly offset from the centre.
One embodiment of the invention will now be described, by way of example only, with reference to the accompanying diagrammatic drawings, of which: Figure 1 is a view of a bag according to the invention, and
Figure 2 is a view, in section along line II-II of Figure 1, of a cryoprotectant storage bag.
A freezing bag 10 (Figure 1) suitable for use with the method of PCT/GB90/140 has, situated at one end of an edge 20, an inlet port 11 connected to a tube 12 having a breakable seal 13- A branch 14 from the tube 12 leads to a cryoprotectant storage bag 15 which is surrounded by a cover 16 (see Figure 2) made of impervious material. The cover 16 extends for a sufficient length of the branch 14 to insure that it will overlie any position to which cryoprotectant will penetrate.
At approximately the centre, but slightly offset from the centre, of the edge 20 is an outlet port 17 having a breakable seal
18. The outlet port 17 and seal 18 might conveniently be of the type used on conventional (non- frozen) storage bags.
In use the cover 16 is removed from the cryoprotectant storage bag 15 and the breakable seal 13 removed from the tube 12, which is connected to a red blood cell supply (not shown) in known manner.
Blood from a donor is centrifuged and the red cells therefrom passed through the tube 12 to the bag 10, cryoprotectant from the cryoprotectant storage bag 15 being passed through the branch 14 and tube 12 at the same time. The bag is then sealed, for example by thermally sealing along a line 19, in known fashion, and then removing the inlet port 11 and associated items. The bag 10 is then shaken to mix the red blood cells and cryoprotectant, frozen and stored according to the method of PCT/GB90/140.
When it is required to use the stored blood it is defrozen according to the method of PCT/GB90/140, the breakable seal 18 removed, and the outlet port 17 connected to transfusion means in the standard way.
It will be realised that with the outlet port 17 offset from the centre of the edge 20 a number of bags 10 may be stored in "back to back" fashion, such that adjacent ports 17 do not overlie, reducing the storage space required for a number of bags.
Many variations of the invention will be apparent to those skilled in the art. For example the cryoprotectant storage bag 15 might be formed of impermeable material, there then being no need for a separate cover 16. However this arrangement makes it harder to protect cryoprotectant entering the branch 14.
Materials suitable for use with the bag 10 and other items will readily be apparent to those skilled in the art. For example, many plastic materials having the required flexibility and suitability for use at low temperatures, are available commercially, and metallised plastics material may also be used.

Claims

CLAIMSWhat is claimed is;
1. A freezing bag (10) having an inlet port (11) connected to an inlet tube (12) characterised in that the inlet tube (12) is connected to a cryoprotectant storage bag (15) having an impervious cover (16), and an outlet port (17). the inlet tube (12) and the outlet port (17) each having a breakable seal (13. 18) .
2. A freezing bag as claimed in Claim 1 characterised in that the impervious cover (16) is separate from the storage bag (15).
3. A freezing bag as claimed in Claim 1 or in Claim 2 characterised in that it is of generally rectangular shape.
4. A freezing bag as claimed in Claim 3 characterised in that it is of generally square shape.
5. A freezing bag as claimed in any one of Claims 1 to 4 characterised in that the inlet port (11) and outlet port (17) are on a same edge (20) of the bag.
6. A freezing bag as claimed in any one of Claims 1 to 5 characterised in that the outlet port (17) is positioned towards the centre of an edge (20) of the bag.
7. A freezing bag as claimed in Claim 6 characterised in that the outlet port (17) is offset from the centre of the edge.
8. A freezing bag substantially as herein described with reference to Figures 1 and 2 of the accompanying drawings.
PCT/GB1993/000975 1992-06-15 1993-05-12 Freezing bags WO1993025176A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9400647A GB2272883B (en) 1992-06-15 1993-05-12 Freezing bags

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929212622A GB9212622D0 (en) 1992-06-15 1992-06-15 Freezing bags
GB9212622.6 1992-06-15

Publications (1)

Publication Number Publication Date
WO1993025176A1 true WO1993025176A1 (en) 1993-12-23

Family

ID=10717081

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1993/000975 WO1993025176A1 (en) 1992-06-15 1993-05-12 Freezing bags

Country Status (2)

Country Link
GB (2) GB9212622D0 (en)
WO (1) WO1993025176A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006027565A1 (en) * 2004-09-09 2006-03-16 Lifeforce Group Plc Apheresis tubing set
WO2008035240A2 (en) * 2006-07-19 2008-03-27 Medical Mediterranea S.R.L. Platelet freezing system

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077189A1 (en) * 1981-10-09 1983-04-20 Biofusion (Proprietary) Limited An infusion unit
EP0253651A2 (en) * 1986-07-16 1988-01-20 Autologous Blood Corporation Method for storing and processing blood
WO1989004280A1 (en) * 1987-11-04 1989-05-18 Drg (Uk) Limited Fluid containers and ports therefor
WO1990005495A1 (en) * 1988-11-15 1990-05-31 Baxter International Inc. Apparatus and method for collecting and freezing blood plasma
WO1990009184A1 (en) * 1989-02-08 1990-08-23 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland A method of freezing red blood cells

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077189A1 (en) * 1981-10-09 1983-04-20 Biofusion (Proprietary) Limited An infusion unit
EP0253651A2 (en) * 1986-07-16 1988-01-20 Autologous Blood Corporation Method for storing and processing blood
WO1989004280A1 (en) * 1987-11-04 1989-05-18 Drg (Uk) Limited Fluid containers and ports therefor
WO1990005495A1 (en) * 1988-11-15 1990-05-31 Baxter International Inc. Apparatus and method for collecting and freezing blood plasma
WO1990009184A1 (en) * 1989-02-08 1990-08-23 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland A method of freezing red blood cells

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006027565A1 (en) * 2004-09-09 2006-03-16 Lifeforce Group Plc Apheresis tubing set
WO2008035240A2 (en) * 2006-07-19 2008-03-27 Medical Mediterranea S.R.L. Platelet freezing system
WO2008035240A3 (en) * 2006-07-19 2008-09-12 Medical Mediterranea S R L Platelet freezing system

Also Published As

Publication number Publication date
GB9400647D0 (en) 1994-03-09
GB9212622D0 (en) 1992-07-29
GB2272883A (en) 1994-06-01
GB2272883B (en) 1996-01-31

Similar Documents

Publication Publication Date Title
US4994021A (en) Apparatus and method for collecting and freezing blood plasma
US4131200A (en) Thermoplastic blood bag
US3986506A (en) Apparatus for separation of cryoprecipitate from blood plasma and method
EP0540732B1 (en) Systems and methods for removing undesired matter from blood cells
US3064647A (en) Blood component separation method and apparatus
US4198972A (en) Blood and blood component storage bags
US5770051A (en) Apparatus for separating blood in an integrally formed container
USRE27132E (en) Apparatus for treating blood
US4018222A (en) Syringe containing frozen vaccine
US20080234653A1 (en) Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US10806665B2 (en) System and method for freeze-drying and packaging
EP0233112A1 (en) Method for separation of blood components and apparatus therefor
CN109152698B (en) Plasma bottle without sealing piece and top cover thereof
EP0728522B1 (en) Blood collection assembly having additive dispensing means and method for sample collection using same
WO1993025176A1 (en) Freezing bags
US20060167401A1 (en) Apparatus and method for stem cell preservation and usage
AU674163B2 (en) Freezing bags
IL47945A (en) Method and apparatus for the separation of cryprecipitate separation of cryoprecipitate from blood plasma
JPS63132658A (en) Blood preserving container
EP0720468B1 (en) Freezing frames for blood bags
EP2982374A1 (en) Red blood cell storage solution, storage solution accommodating container, manufacturing method for red blood cell storage solution, and red blood cell bag system
EP0420757B1 (en) Multiple blood bag system
US3945523A (en) Freeze storage container system
RU2740839C1 (en) Container for lyophilisation and transfusion of hemocomponents
JPH02152455A (en) Container and method for preserving platelet

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA GB US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA